This study aims to gather information to what extent patients follow the treatment regimen of low-dose aspirin for primary and secondary prevention of diseases of the heart and blood vessels. Researcher will collect information about the percentage of time a patient has access to the medication, how long patients continue with the medication and of the proportion of patients who switch from dual-antiplatelet therapy (including low-dose aspirin) to a single antiplatelet therapy. The study will make use of secondary healthcare data sources converted in to Observational Medical Outcomes Partnership (OMOP) common data model within the Observational Health Data Sciences and Informatics (OHDSI) network.
Study Type
OBSERVATIONAL
Enrollment
99,999
75-100mg
Many Locations
Multiple Locations, Germany
Many Locations
Multiple Locations, United Kingdom
Adherence to low-dose aspirin
Adherence low-dose aspirin use will be represented by the medication possession ratio (MPR)
Time frame: Retrospective analysis from 2007 to 2018
Persistence to low-dose aspirin
In terms of continuation and discontinuation: * Continuation at 30 and 60 day gaps * Discontinuation: * If patients switched to another antiplatelet therapy * If patients reinitiated low-dose aspirin \>30 days and \>60 days after end of supply i.e. of the pre-specified gap was exceeded * If patients stopped low-dose aspirin therapy completely
Time frame: Retrospective analysis from 2007 to 2018
Time to switch from dual-antiplatelet to a monotherapy
Time frame: Retrospective analysis from 2007 to 2018
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.